The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The close medium term support offers good timing for purchasing the stock.
The group's high margin levels account for strong profits.
The company is in a robust financial situation considering its net cash and margin position.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Historically, the company has been releasing figures that are above expectations.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
With an enterprise value anticipated at 4.2 times the sales for the current fiscal year, the company turns out to be overvalued.
The company is not the most generous with respect to shareholders' compensation.
Sector Advanced Medical Equipment & Technology - NEC